nodes	percent_of_prediction	percent_of_DWPC	metapath
Rosiglitazone—PPARG—Sulfasalazine—ankylosing spondylitis	0.335	0.373	CbGbCtD
Rosiglitazone—SLCO1B1—Sulfasalazine—ankylosing spondylitis	0.115	0.128	CbGbCtD
Rosiglitazone—PTGS1—Sulfasalazine—ankylosing spondylitis	0.0845	0.0939	CbGbCtD
Rosiglitazone—CYP2A6—Prednisolone—ankylosing spondylitis	0.0837	0.093	CbGbCtD
Rosiglitazone—ALB—Prednisone—ankylosing spondylitis	0.0504	0.0561	CbGbCtD
Rosiglitazone—CYP2A6—Dexamethasone—ankylosing spondylitis	0.0494	0.0548	CbGbCtD
Rosiglitazone—SLCO1B1—Methotrexate—ankylosing spondylitis	0.0462	0.0514	CbGbCtD
Rosiglitazone—CYP2C19—Prednisone—ankylosing spondylitis	0.0327	0.0363	CbGbCtD
Rosiglitazone—ALB—Methotrexate—ankylosing spondylitis	0.0253	0.0281	CbGbCtD
Rosiglitazone—CYP2C8—Dexamethasone—ankylosing spondylitis	0.0243	0.027	CbGbCtD
Rosiglitazone—CYP2C19—Dexamethasone—ankylosing spondylitis	0.0204	0.0227	CbGbCtD
Rosiglitazone—CYP2C9—Dexamethasone—ankylosing spondylitis	0.017	0.0189	CbGbCtD
Rosiglitazone—CYP2D6—Dexamethasone—ankylosing spondylitis	0.0155	0.0172	CbGbCtD
Rosiglitazone—Haematocrit decreased—Methotrexate—ankylosing spondylitis	0.00165	0.0165	CcSEcCtD
Rosiglitazone—Multiple fractures—Methylprednisolone—ankylosing spondylitis	0.0016	0.016	CcSEcCtD
Rosiglitazone—Fracture—Methylprednisolone—ankylosing spondylitis	0.0016	0.016	CcSEcCtD
Rosiglitazone—Multiple fractures—Betamethasone—ankylosing spondylitis	0.00146	0.0145	CcSEcCtD
Rosiglitazone—Multiple fractures—Dexamethasone—ankylosing spondylitis	0.00146	0.0145	CcSEcCtD
Rosiglitazone—Fracture—Betamethasone—ankylosing spondylitis	0.00146	0.0145	CcSEcCtD
Rosiglitazone—Fracture—Dexamethasone—ankylosing spondylitis	0.00146	0.0145	CcSEcCtD
Rosiglitazone—Visual acuity reduced—Dexamethasone—ankylosing spondylitis	0.00142	0.0142	CcSEcCtD
Rosiglitazone—Visual acuity reduced—Betamethasone—ankylosing spondylitis	0.00142	0.0142	CcSEcCtD
Rosiglitazone—Hypertriglyceridaemia—Prednisone—ankylosing spondylitis	0.00128	0.0128	CcSEcCtD
Rosiglitazone—Fracture—Prednisone—ankylosing spondylitis	0.00127	0.0127	CcSEcCtD
Rosiglitazone—Multiple fractures—Prednisone—ankylosing spondylitis	0.00127	0.0127	CcSEcCtD
Rosiglitazone—Blood triglycerides increased—Prednisone—ankylosing spondylitis	0.00113	0.0112	CcSEcCtD
Rosiglitazone—Multiple fractures—Methotrexate—ankylosing spondylitis	0.00106	0.0106	CcSEcCtD
Rosiglitazone—Fracture—Methotrexate—ankylosing spondylitis	0.00106	0.0106	CcSEcCtD
Rosiglitazone—Fluid retention—Prednisolone—ankylosing spondylitis	0.000963	0.00962	CcSEcCtD
Rosiglitazone—Pulmonary oedema—Prednisolone—ankylosing spondylitis	0.000903	0.00902	CcSEcCtD
Rosiglitazone—Fluid retention—Triamcinolone—ankylosing spondylitis	0.000886	0.00885	CcSEcCtD
Rosiglitazone—Fluid retention—Methylprednisolone—ankylosing spondylitis	0.000884	0.00883	CcSEcCtD
Rosiglitazone—Diabetes mellitus—Prednisolone—ankylosing spondylitis	0.000847	0.00846	CcSEcCtD
Rosiglitazone—Pulmonary oedema—Triamcinolone—ankylosing spondylitis	0.00083	0.00829	CcSEcCtD
Rosiglitazone—Pulmonary oedema—Methylprednisolone—ankylosing spondylitis	0.000829	0.00828	CcSEcCtD
Rosiglitazone—Cardiac failure congestive—Prednisolone—ankylosing spondylitis	0.000812	0.00811	CcSEcCtD
Rosiglitazone—Pleural effusion—Methotrexate—ankylosing spondylitis	0.000805	0.00804	CcSEcCtD
Rosiglitazone—Fluid retention—Betamethasone—ankylosing spondylitis	0.000804	0.00803	CcSEcCtD
Rosiglitazone—Fluid retention—Dexamethasone—ankylosing spondylitis	0.000804	0.00803	CcSEcCtD
Rosiglitazone—Increased appetite—Prednisolone—ankylosing spondylitis	0.000784	0.00783	CcSEcCtD
Rosiglitazone—Hypercholesterolaemia—Prednisone—ankylosing spondylitis	0.000779	0.00778	CcSEcCtD
Rosiglitazone—Diabetes mellitus—Triamcinolone—ankylosing spondylitis	0.000779	0.00778	CcSEcCtD
Rosiglitazone—Diabetes mellitus—Methylprednisolone—ankylosing spondylitis	0.000777	0.00776	CcSEcCtD
Rosiglitazone—Pulmonary oedema—Dexamethasone—ankylosing spondylitis	0.000753	0.00753	CcSEcCtD
Rosiglitazone—Pulmonary oedema—Betamethasone—ankylosing spondylitis	0.000753	0.00753	CcSEcCtD
Rosiglitazone—Cardiac failure congestive—Triamcinolone—ankylosing spondylitis	0.000747	0.00746	CcSEcCtD
Rosiglitazone—Cardiac failure congestive—Methylprednisolone—ankylosing spondylitis	0.000745	0.00744	CcSEcCtD
Rosiglitazone—Increased appetite—Triamcinolone—ankylosing spondylitis	0.000721	0.0072	CcSEcCtD
Rosiglitazone—Increased appetite—Methylprednisolone—ankylosing spondylitis	0.000719	0.00718	CcSEcCtD
Rosiglitazone—Diabetes mellitus—Betamethasone—ankylosing spondylitis	0.000706	0.00706	CcSEcCtD
Rosiglitazone—Diabetes mellitus—Dexamethasone—ankylosing spondylitis	0.000706	0.00706	CcSEcCtD
Rosiglitazone—Fluid retention—Prednisone—ankylosing spondylitis	0.0007	0.00699	CcSEcCtD
Rosiglitazone—Cardiac failure—Methylprednisolone—ankylosing spondylitis	0.000692	0.00692	CcSEcCtD
Rosiglitazone—Cardiac failure congestive—Dexamethasone—ankylosing spondylitis	0.000678	0.00677	CcSEcCtD
Rosiglitazone—Cardiac failure congestive—Betamethasone—ankylosing spondylitis	0.000678	0.00677	CcSEcCtD
Rosiglitazone—Hyperbilirubinaemia—Methotrexate—ankylosing spondylitis	0.000678	0.00677	CcSEcCtD
Rosiglitazone—Pulmonary oedema—Prednisone—ankylosing spondylitis	0.000656	0.00655	CcSEcCtD
Rosiglitazone—Increased appetite—Dexamethasone—ankylosing spondylitis	0.000654	0.00653	CcSEcCtD
Rosiglitazone—Increased appetite—Betamethasone—ankylosing spondylitis	0.000654	0.00653	CcSEcCtD
Rosiglitazone—Hepatic enzyme increased—Methotrexate—ankylosing spondylitis	0.000651	0.00651	CcSEcCtD
Rosiglitazone—Cardiac failure—Betamethasone—ankylosing spondylitis	0.00063	0.00629	CcSEcCtD
Rosiglitazone—Cardiac failure—Dexamethasone—ankylosing spondylitis	0.00063	0.00629	CcSEcCtD
Rosiglitazone—Diabetes mellitus—Prednisone—ankylosing spondylitis	0.000615	0.00615	CcSEcCtD
Rosiglitazone—Cardiac failure congestive—Prednisone—ankylosing spondylitis	0.00059	0.00589	CcSEcCtD
Rosiglitazone—Weight increased—Prednisolone—ankylosing spondylitis	0.000579	0.00579	CcSEcCtD
Rosiglitazone—Increased appetite—Prednisone—ankylosing spondylitis	0.00057	0.00569	CcSEcCtD
Rosiglitazone—Acute coronary syndrome—Prednisolone—ankylosing spondylitis	0.000559	0.00559	CcSEcCtD
Rosiglitazone—Myocardial infarction—Prednisolone—ankylosing spondylitis	0.000556	0.00556	CcSEcCtD
Rosiglitazone—Pulmonary oedema—Methotrexate—ankylosing spondylitis	0.000548	0.00548	CcSEcCtD
Rosiglitazone—Cardiac failure—Prednisone—ankylosing spondylitis	0.000548	0.00548	CcSEcCtD
Rosiglitazone—Upper respiratory tract infection—Triamcinolone—ankylosing spondylitis	0.000544	0.00543	CcSEcCtD
Rosiglitazone—Weight increased—Triamcinolone—ankylosing spondylitis	0.000533	0.00532	CcSEcCtD
Rosiglitazone—Weight increased—Methylprednisolone—ankylosing spondylitis	0.000531	0.00531	CcSEcCtD
Rosiglitazone—Acute coronary syndrome—Triamcinolone—ankylosing spondylitis	0.000514	0.00514	CcSEcCtD
Rosiglitazone—Diabetes mellitus—Methotrexate—ankylosing spondylitis	0.000514	0.00514	CcSEcCtD
Rosiglitazone—Acute coronary syndrome—Methylprednisolone—ankylosing spondylitis	0.000513	0.00513	CcSEcCtD
Rosiglitazone—Myocardial infarction—Triamcinolone—ankylosing spondylitis	0.000512	0.00511	CcSEcCtD
Rosiglitazone—Myocardial infarction—Methylprednisolone—ankylosing spondylitis	0.00051	0.0051	CcSEcCtD
Rosiglitazone—Hepatic failure—Methotrexate—ankylosing spondylitis	0.000498	0.00497	CcSEcCtD
Rosiglitazone—Weight increased—Dexamethasone—ankylosing spondylitis	0.000483	0.00483	CcSEcCtD
Rosiglitazone—Weight increased—Betamethasone—ankylosing spondylitis	0.000483	0.00483	CcSEcCtD
Rosiglitazone—Hyperglycaemia—Dexamethasone—ankylosing spondylitis	0.000479	0.00479	CcSEcCtD
Rosiglitazone—Hyperglycaemia—Betamethasone—ankylosing spondylitis	0.000479	0.00479	CcSEcCtD
Rosiglitazone—Acute coronary syndrome—Dexamethasone—ankylosing spondylitis	0.000467	0.00466	CcSEcCtD
Rosiglitazone—Acute coronary syndrome—Betamethasone—ankylosing spondylitis	0.000467	0.00466	CcSEcCtD
Rosiglitazone—Myocardial infarction—Dexamethasone—ankylosing spondylitis	0.000464	0.00464	CcSEcCtD
Rosiglitazone—Myocardial infarction—Betamethasone—ankylosing spondylitis	0.000464	0.00464	CcSEcCtD
Rosiglitazone—Connective tissue disorder—Methylprednisolone—ankylosing spondylitis	0.000459	0.00459	CcSEcCtD
Rosiglitazone—Cerebrovascular accident—Methotrexate—ankylosing spondylitis	0.000456	0.00456	CcSEcCtD
Rosiglitazone—Eye disorder—Methylprednisolone—ankylosing spondylitis	0.000437	0.00436	CcSEcCtD
Rosiglitazone—Cardiac disorder—Methylprednisolone—ankylosing spondylitis	0.000434	0.00433	CcSEcCtD
Rosiglitazone—Immune system disorder—Methylprednisolone—ankylosing spondylitis	0.000422	0.00422	CcSEcCtD
Rosiglitazone—Weight increased—Prednisone—ankylosing spondylitis	0.000421	0.0042	CcSEcCtD
Rosiglitazone—Hyperglycaemia—Prednisone—ankylosing spondylitis	0.000417	0.00417	CcSEcCtD
Rosiglitazone—Malnutrition—Methylprednisolone—ankylosing spondylitis	0.000407	0.00406	CcSEcCtD
Rosiglitazone—Acute coronary syndrome—Prednisone—ankylosing spondylitis	0.000407	0.00406	CcSEcCtD
Rosiglitazone—Angioedema—Prednisolone—ankylosing spondylitis	0.000405	0.00405	CcSEcCtD
Rosiglitazone—Myocardial infarction—Prednisone—ankylosing spondylitis	0.000404	0.00404	CcSEcCtD
Rosiglitazone—Eye disorder—Dexamethasone—ankylosing spondylitis	0.000397	0.00397	CcSEcCtD
Rosiglitazone—Eye disorder—Betamethasone—ankylosing spondylitis	0.000397	0.00397	CcSEcCtD
Rosiglitazone—Back pain—Triamcinolone—ankylosing spondylitis	0.000394	0.00394	CcSEcCtD
Rosiglitazone—Hypertension—Prednisolone—ankylosing spondylitis	0.000383	0.00382	CcSEcCtD
Rosiglitazone—Angioedema—Triamcinolone—ankylosing spondylitis	0.000373	0.00372	CcSEcCtD
Rosiglitazone—Angioedema—Methylprednisolone—ankylosing spondylitis	0.000372	0.00371	CcSEcCtD
Rosiglitazone—Connective tissue disorder—Prednisone—ankylosing spondylitis	0.000364	0.00363	CcSEcCtD
Rosiglitazone—Anaphylactic shock—Prednisolone—ankylosing spondylitis	0.000362	0.00362	CcSEcCtD
Rosiglitazone—Oedema—Prednisolone—ankylosing spondylitis	0.000362	0.00362	CcSEcCtD
Rosiglitazone—Upper respiratory tract infection—Methotrexate—ankylosing spondylitis	0.000359	0.00359	CcSEcCtD
Rosiglitazone—Hypertension—Triamcinolone—ankylosing spondylitis	0.000352	0.00352	CcSEcCtD
Rosiglitazone—Hypertension—Methylprednisolone—ankylosing spondylitis	0.000351	0.00351	CcSEcCtD
Rosiglitazone—Myalgia—Triamcinolone—ankylosing spondylitis	0.000347	0.00347	CcSEcCtD
Rosiglitazone—Myalgia—Methylprednisolone—ankylosing spondylitis	0.000346	0.00346	CcSEcCtD
Rosiglitazone—Arthralgia—Methylprednisolone—ankylosing spondylitis	0.000346	0.00346	CcSEcCtD
Rosiglitazone—Eye disorder—Prednisone—ankylosing spondylitis	0.000346	0.00346	CcSEcCtD
Rosiglitazone—Stevens-Johnson syndrome—Methotrexate—ankylosing spondylitis	0.000342	0.00341	CcSEcCtD
Rosiglitazone—Angioedema—Betamethasone—ankylosing spondylitis	0.000338	0.00338	CcSEcCtD
Rosiglitazone—Angioedema—Dexamethasone—ankylosing spondylitis	0.000338	0.00338	CcSEcCtD
Rosiglitazone—Immune system disorder—Prednisone—ankylosing spondylitis	0.000334	0.00334	CcSEcCtD
Rosiglitazone—Anaphylactic shock—Triamcinolone—ankylosing spondylitis	0.000333	0.00332	CcSEcCtD
Rosiglitazone—Oedema—Triamcinolone—ankylosing spondylitis	0.000333	0.00332	CcSEcCtD
Rosiglitazone—Anaphylactic shock—Methylprednisolone—ankylosing spondylitis	0.000332	0.00332	CcSEcCtD
Rosiglitazone—Infection—Triamcinolone—ankylosing spondylitis	0.000331	0.0033	CcSEcCtD
Rosiglitazone—Infection—Methylprednisolone—ankylosing spondylitis	0.00033	0.0033	CcSEcCtD
Rosiglitazone—Hepatobiliary disease—Methotrexate—ankylosing spondylitis	0.000326	0.00326	CcSEcCtD
Rosiglitazone—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.000326	0.00325	CcSEcCtD
Rosiglitazone—Malnutrition—Prednisone—ankylosing spondylitis	0.000322	0.00322	CcSEcCtD
Rosiglitazone—Hypertension—Dexamethasone—ankylosing spondylitis	0.000319	0.00319	CcSEcCtD
Rosiglitazone—Hypertension—Betamethasone—ankylosing spondylitis	0.000319	0.00319	CcSEcCtD
Rosiglitazone—Myalgia—Betamethasone—ankylosing spondylitis	0.000315	0.00315	CcSEcCtD
Rosiglitazone—Myalgia—Dexamethasone—ankylosing spondylitis	0.000315	0.00315	CcSEcCtD
Rosiglitazone—Hepatitis—Methotrexate—ankylosing spondylitis	0.000309	0.00309	CcSEcCtD
Rosiglitazone—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.000303	0.00303	CcSEcCtD
Rosiglitazone—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.000303	0.00302	CcSEcCtD
Rosiglitazone—Oedema—Dexamethasone—ankylosing spondylitis	0.000302	0.00302	CcSEcCtD
Rosiglitazone—Oedema—Betamethasone—ankylosing spondylitis	0.000302	0.00302	CcSEcCtD
Rosiglitazone—Anaphylactic shock—Dexamethasone—ankylosing spondylitis	0.000302	0.00302	CcSEcCtD
Rosiglitazone—Anaphylactic shock—Betamethasone—ankylosing spondylitis	0.000302	0.00302	CcSEcCtD
Rosiglitazone—Infection—Dexamethasone—ankylosing spondylitis	0.0003	0.003	CcSEcCtD
Rosiglitazone—Infection—Betamethasone—ankylosing spondylitis	0.0003	0.003	CcSEcCtD
Rosiglitazone—Anaemia—Prednisone—ankylosing spondylitis	0.000298	0.00298	CcSEcCtD
Rosiglitazone—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.000296	0.00296	CcSEcCtD
Rosiglitazone—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.000296	0.00296	CcSEcCtD
Rosiglitazone—Thrombocytopenia—Dexamethasone—ankylosing spondylitis	0.000296	0.00295	CcSEcCtD
Rosiglitazone—Thrombocytopenia—Betamethasone—ankylosing spondylitis	0.000296	0.00295	CcSEcCtD
Rosiglitazone—Angioedema—Prednisone—ankylosing spondylitis	0.000294	0.00294	CcSEcCtD
Rosiglitazone—Erythema multiforme—Methotrexate—ankylosing spondylitis	0.000293	0.00292	CcSEcCtD
Rosiglitazone—Eye disorder—Methotrexate—ankylosing spondylitis	0.000289	0.00289	CcSEcCtD
Rosiglitazone—Urticaria—Prednisolone—ankylosing spondylitis	0.000288	0.00287	CcSEcCtD
Rosiglitazone—Cardiac disorder—Methotrexate—ankylosing spondylitis	0.000287	0.00287	CcSEcCtD
Rosiglitazone—Fatigue—Triamcinolone—ankylosing spondylitis	0.000287	0.00287	CcSEcCtD
Rosiglitazone—Fatigue—Methylprednisolone—ankylosing spondylitis	0.000286	0.00286	CcSEcCtD
Rosiglitazone—Immune system disorder—Methotrexate—ankylosing spondylitis	0.000279	0.00279	CcSEcCtD
Rosiglitazone—Hypertension—Prednisone—ankylosing spondylitis	0.000278	0.00278	CcSEcCtD
Rosiglitazone—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.000275	0.00275	CcSEcCtD
Rosiglitazone—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.000275	0.00275	CcSEcCtD
Rosiglitazone—Arthralgia—Prednisone—ankylosing spondylitis	0.000274	0.00274	CcSEcCtD
Rosiglitazone—Myalgia—Prednisone—ankylosing spondylitis	0.000274	0.00274	CcSEcCtD
Rosiglitazone—Malnutrition—Methotrexate—ankylosing spondylitis	0.000269	0.00269	CcSEcCtD
Rosiglitazone—Urticaria—Triamcinolone—ankylosing spondylitis	0.000264	0.00264	CcSEcCtD
Rosiglitazone—Urticaria—Methylprednisolone—ankylosing spondylitis	0.000264	0.00264	CcSEcCtD
Rosiglitazone—Anaphylactic shock—Prednisone—ankylosing spondylitis	0.000263	0.00263	CcSEcCtD
Rosiglitazone—Oedema—Prednisone—ankylosing spondylitis	0.000263	0.00263	CcSEcCtD
Rosiglitazone—Infection—Prednisone—ankylosing spondylitis	0.000261	0.00261	CcSEcCtD
Rosiglitazone—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.000261	0.0026	CcSEcCtD
Rosiglitazone—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.000261	0.0026	CcSEcCtD
Rosiglitazone—Back pain—Methotrexate—ankylosing spondylitis	0.000261	0.0026	CcSEcCtD
Rosiglitazone—Fatigue—Dexamethasone—ankylosing spondylitis	0.00026	0.0026	CcSEcCtD
Rosiglitazone—Fatigue—Betamethasone—ankylosing spondylitis	0.00026	0.0026	CcSEcCtD
Rosiglitazone—Nervous system disorder—Prednisone—ankylosing spondylitis	0.000258	0.00258	CcSEcCtD
Rosiglitazone—Anaemia—Methotrexate—ankylosing spondylitis	0.000249	0.00249	CcSEcCtD
Rosiglitazone—Leukopenia—Methotrexate—ankylosing spondylitis	0.000241	0.00241	CcSEcCtD
Rosiglitazone—Urticaria—Betamethasone—ankylosing spondylitis	0.00024	0.0024	CcSEcCtD
Rosiglitazone—Urticaria—Dexamethasone—ankylosing spondylitis	0.00024	0.0024	CcSEcCtD
Rosiglitazone—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.00024	0.00239	CcSEcCtD
Rosiglitazone—Dizziness—Prednisolone—ankylosing spondylitis	0.000239	0.00239	CcSEcCtD
Rosiglitazone—Asthenia—Triamcinolone—ankylosing spondylitis	0.000239	0.00239	CcSEcCtD
Rosiglitazone—Asthenia—Methylprednisolone—ankylosing spondylitis	0.000238	0.00238	CcSEcCtD
Rosiglitazone—Pruritus—Triamcinolone—ankylosing spondylitis	0.000235	0.00235	CcSEcCtD
Rosiglitazone—Pruritus—Methylprednisolone—ankylosing spondylitis	0.000235	0.00235	CcSEcCtD
Rosiglitazone—Arthralgia—Methotrexate—ankylosing spondylitis	0.000229	0.00229	CcSEcCtD
Rosiglitazone—Myalgia—Methotrexate—ankylosing spondylitis	0.000229	0.00229	CcSEcCtD
Rosiglitazone—Rash—Prednisolone—ankylosing spondylitis	0.000228	0.00228	CcSEcCtD
Rosiglitazone—Dermatitis—Prednisolone—ankylosing spondylitis	0.000228	0.00228	CcSEcCtD
Rosiglitazone—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.000227	0.00227	CcSEcCtD
Rosiglitazone—Fatigue—Prednisone—ankylosing spondylitis	0.000227	0.00226	CcSEcCtD
Rosiglitazone—Headache—Prednisolone—ankylosing spondylitis	0.000227	0.00226	CcSEcCtD
Rosiglitazone—Constipation—Prednisone—ankylosing spondylitis	0.000225	0.00225	CcSEcCtD
Rosiglitazone—Dizziness—Triamcinolone—ankylosing spondylitis	0.00022	0.0022	CcSEcCtD
Rosiglitazone—Anaphylactic shock—Methotrexate—ankylosing spondylitis	0.00022	0.0022	CcSEcCtD
Rosiglitazone—Dizziness—Methylprednisolone—ankylosing spondylitis	0.00022	0.00219	CcSEcCtD
Rosiglitazone—Infection—Methotrexate—ankylosing spondylitis	0.000218	0.00218	CcSEcCtD
Rosiglitazone—Asthenia—Betamethasone—ankylosing spondylitis	0.000217	0.00216	CcSEcCtD
Rosiglitazone—Asthenia—Dexamethasone—ankylosing spondylitis	0.000217	0.00216	CcSEcCtD
Rosiglitazone—Nervous system disorder—Methotrexate—ankylosing spondylitis	0.000216	0.00215	CcSEcCtD
Rosiglitazone—Thrombocytopenia—Methotrexate—ankylosing spondylitis	0.000215	0.00215	CcSEcCtD
Rosiglitazone—Nausea—Prednisolone—ankylosing spondylitis	0.000215	0.00215	CcSEcCtD
Rosiglitazone—Pruritus—Betamethasone—ankylosing spondylitis	0.000214	0.00213	CcSEcCtD
Rosiglitazone—Pruritus—Dexamethasone—ankylosing spondylitis	0.000214	0.00213	CcSEcCtD
Rosiglitazone—Rash—Triamcinolone—ankylosing spondylitis	0.00021	0.0021	CcSEcCtD
Rosiglitazone—Dermatitis—Triamcinolone—ankylosing spondylitis	0.00021	0.00209	CcSEcCtD
Rosiglitazone—Rash—Methylprednisolone—ankylosing spondylitis	0.000209	0.00209	CcSEcCtD
Rosiglitazone—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.000209	0.00209	CcSEcCtD
Rosiglitazone—Urticaria—Prednisone—ankylosing spondylitis	0.000209	0.00209	CcSEcCtD
Rosiglitazone—Headache—Triamcinolone—ankylosing spondylitis	0.000209	0.00208	CcSEcCtD
Rosiglitazone—Headache—Methylprednisolone—ankylosing spondylitis	0.000208	0.00208	CcSEcCtD
Rosiglitazone—Diarrhoea—Betamethasone—ankylosing spondylitis	0.000207	0.00206	CcSEcCtD
Rosiglitazone—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.000207	0.00206	CcSEcCtD
Rosiglitazone—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	0.0002	0.002	CcSEcCtD
Rosiglitazone—Dizziness—Betamethasone—ankylosing spondylitis	0.0002	0.00199	CcSEcCtD
Rosiglitazone—Dizziness—Dexamethasone—ankylosing spondylitis	0.0002	0.00199	CcSEcCtD
Rosiglitazone—Nausea—Triamcinolone—ankylosing spondylitis	0.000198	0.00197	CcSEcCtD
Rosiglitazone—Nausea—Methylprednisolone—ankylosing spondylitis	0.000197	0.00197	CcSEcCtD
Rosiglitazone—Rash—Betamethasone—ankylosing spondylitis	0.00019	0.0019	CcSEcCtD
Rosiglitazone—Rash—Dexamethasone—ankylosing spondylitis	0.00019	0.0019	CcSEcCtD
Rosiglitazone—Dermatitis—Betamethasone—ankylosing spondylitis	0.00019	0.0019	CcSEcCtD
Rosiglitazone—Dermatitis—Dexamethasone—ankylosing spondylitis	0.00019	0.0019	CcSEcCtD
Rosiglitazone—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.00019	0.0019	CcSEcCtD
Rosiglitazone—Fatigue—Methotrexate—ankylosing spondylitis	0.00019	0.00189	CcSEcCtD
Rosiglitazone—Headache—Dexamethasone—ankylosing spondylitis	0.000189	0.00189	CcSEcCtD
Rosiglitazone—Headache—Betamethasone—ankylosing spondylitis	0.000189	0.00189	CcSEcCtD
Rosiglitazone—Asthenia—Prednisone—ankylosing spondylitis	0.000189	0.00188	CcSEcCtD
Rosiglitazone—Pruritus—Prednisone—ankylosing spondylitis	0.000186	0.00186	CcSEcCtD
Rosiglitazone—Diarrhoea—Prednisone—ankylosing spondylitis	0.00018	0.0018	CcSEcCtD
Rosiglitazone—Nausea—Dexamethasone—ankylosing spondylitis	0.000179	0.00179	CcSEcCtD
Rosiglitazone—Nausea—Betamethasone—ankylosing spondylitis	0.000179	0.00179	CcSEcCtD
Rosiglitazone—Urticaria—Methotrexate—ankylosing spondylitis	0.000175	0.00174	CcSEcCtD
Rosiglitazone—Dizziness—Prednisone—ankylosing spondylitis	0.000174	0.00174	CcSEcCtD
Rosiglitazone—Rash—Prednisone—ankylosing spondylitis	0.000166	0.00166	CcSEcCtD
Rosiglitazone—Dermatitis—Prednisone—ankylosing spondylitis	0.000166	0.00165	CcSEcCtD
Rosiglitazone—Headache—Prednisone—ankylosing spondylitis	0.000165	0.00165	CcSEcCtD
Rosiglitazone—Asthenia—Methotrexate—ankylosing spondylitis	0.000158	0.00158	CcSEcCtD
Rosiglitazone—Nausea—Prednisone—ankylosing spondylitis	0.000156	0.00156	CcSEcCtD
Rosiglitazone—Pruritus—Methotrexate—ankylosing spondylitis	0.000156	0.00155	CcSEcCtD
Rosiglitazone—Diarrhoea—Methotrexate—ankylosing spondylitis	0.00015	0.0015	CcSEcCtD
Rosiglitazone—Dizziness—Methotrexate—ankylosing spondylitis	0.000145	0.00145	CcSEcCtD
Rosiglitazone—Rash—Methotrexate—ankylosing spondylitis	0.000139	0.00138	CcSEcCtD
Rosiglitazone—Dermatitis—Methotrexate—ankylosing spondylitis	0.000138	0.00138	CcSEcCtD
Rosiglitazone—Headache—Methotrexate—ankylosing spondylitis	0.000138	0.00138	CcSEcCtD
Rosiglitazone—Nausea—Methotrexate—ankylosing spondylitis	0.000131	0.0013	CcSEcCtD
